Breaking News Instant updates and real-time market news.

BIIB

Biogen

$292.64

0.17 (0.06%)

, UAL

United Continental

$67.23

-0.94 (-1.38%)

10:41
03/16/17
03/16
10:41
03/16/17
10:41

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) was downgraded to Equal Weight from Overweight at Morgan Stanley and Market Perform from Outperform at Leerink. 2. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI. 3. Tyson Foods (TSN) downgraded to Hold from Buy at Argus with analyst John Staszak citing the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states. 4. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at William Blair with analyst Daniel Hofkin citing the company's fourth quarter results. 5. Inovio (INO) downgraded to Neutral from Overweight at Piper Jaffray with analyst Charles Duncan saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

BIIB

Biogen

$292.64

0.17 (0.06%)

UAL

United Continental

$67.23

-0.94 (-1.38%)

TSN

Tyson Foods

$62.08

-1.02 (-1.62%)

WSM

Williams-Sonoma

$49.47

1.35 (2.81%)

INO

Inovio

$6.87

0.26 (3.93%)

  • 19

    Mar

  • 20

    Mar

  • 20

    Jun

BIIB Biogen
$292.64

0.17 (0.06%)

03/16/17
LEER
03/16/17
DOWNGRADE
Target $300
LEER
Market Perform
Biogen downgraded to Market Perform from Outperform at Leerink
03/16/17
MSCO
03/16/17
DOWNGRADE
Target $305
MSCO
Equal Weight
Biogen downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison downgraded Biogen to Equal Weight and lowered his price target for the shares to $305 from $369.
03/16/17
03/16/17
DOWNGRADE
Target $300

Market Perform
Biogen downgraded to Market Perform at Leerink
As previously reported, Leerink analyst Geoffrey Porges downgraded Biogen to Market Perform from Outperform based on a slower than expected ramp for Spinraza, and the completion of the series of important catalysts that have evolved over the last few months. The analyst is not particularly positive about the other programs in Biogen's late stage pipeline such as BIIB074, BIIB059, STX100 and opicinumab. Porges also lowered his price target on the shares to $300 from $305.
03/16/17
03/16/17
DOWNGRADE

Equal Weight
Biogen cut to Equal Weight as Alzheimer's data awaited at Morgan Stanley
As previously reported, Morgan Stanley analyst Matthew Harrison downgraded Biogen to Equal Weight from Overweight and lowered his price target for the shares to $305 from $369, saying that he sees limited upside for the stock in the near-term. The analyst said his rating change was "not a downside call, but a timing call" as he continues to have a positive view of Alzheimer's candidate aducanumab, though its data is not due until the second half of 2019. In arriving at his $305 price target, Harrison attributes $235 for the base business and $70 per share for aducanumab.
UAL United Continental
$67.23

-0.94 (-1.38%)

01/05/17
01/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Macy's (M) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell saying the company's turnaround initiatives "continue to fall short of expectations." The "discouraging" 2017 forecast reflects the "realities of market share losses" to off-price retail, Amazon (AMZN) and other online threats, Trussell tells investors in a research note after Macy's lowered its outlook. He cut his price target for the shares to $34 from $47. 2. Kohl's (KSS) downgraded to Market Perform from Outperform at Telsey Advisory and to Neutral from Outperform at Baird. 3. DCP Midstream (DPM) downgraded to Sector Perform from Outperform at RBC Capital and to Underperform from Neutral at Credit Suisse. 4. United Continental (UAL) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Rajeev Lalwani saying he changed his rating due to relative outperformance and said further upside might be limited from here. 5. Travelers (TRV) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Kai Pan saying lower reserve releases and rising auto claims present a risk to earnings and post US election share strength underestimates these fundamental headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/22/17
02/22/17
NO CHANGE

Morgan Stanley would not dismiss possibility of Berkshire buying an airline
With Warren Buffett's Berkshire Hathaway (BRK.A) recently disclosing an increase to its overall airline exposure, making the firm a number one or two holder for each of the "Big 4," Morgan Stanley polled investors and found that about 60% do not expect this to be a step towards a full-scale acquisition. However, analyst Rajeev Lalwani said the prospect of Berkshire buying an airline is a possibility that is "not worth dismissing," citing the historical precedent of Buffett's involvement in the rail industry and eventual deal to buy Burlington Northern SantaFe in 2009. The top four U.S. airlines include American Airlines (AAL), Delta Air Lines (DAL), Southwest (LUV) and United Continental (UAL).
03/13/17
UBSW
03/13/17
NO CHANGE
UBSW
Buy
Weakness in airline sector a buying opportunity, says UBS
UBS analyst Darryl Genovisi said the recent dip in airline shares provides a buying opportunity. The analyst noted most of the airlines have cut their PRASM guidance for Q1 and with the miss already priced in and a better outlook for Q2, investors should be buyers of the group. Genovisi prefers United Continental (UAL) followed by Delta (DAL) and Southwest (LUV).
03/16/17
EVER
03/16/17
DOWNGRADE
EVER
In Line
United Continental downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Duane Pfennigwerth downgraded United Continental to In Line.
TSN Tyson Foods
$62.08

-1.02 (-1.62%)

03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded on probe, earnings outlook, bird flu at Argus
As noted earlier, Argus downgraded Tyson Foods to Hold from Buy. As reasons for the downgrade, analyst John Staszak cited the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states.
03/16/17
ARGS
03/16/17
DOWNGRADE
ARGS
Hold
Tyson Foods downgraded to Hold from Buy at Argus
12/02/16
KEYB
12/02/16
INITIATION
KEYB
Overweight
Tyson Foods initiated at KeyBanc
As noted earlier, KeyBanc initiated Tyson Foods with a $70 price target and an Overweight rating. The firm says that concerns about the company are "overdone," while the shares have reached an attractive entry point. It thinks that the company's "significant branded momentum and solid free cash flow" should enable it to carry out share repurchases and potentially make acquisitions. The firm is upbeat on the company's outlook.
02/07/17
JEFF
02/07/17
NO CHANGE
Target $75
JEFF
Buy
Tyson Foods price-fixing allegations unfounded, says Jefferies
Jefferies analyst Akshay Jagdale attributes yesterday's pullback in shares of Tyson Foods to concerns about the newly disclosed SEC investigation and ongoing worries about peaking margins. The SEC investigation represents a short-term overhang but Beef and Pork margins will eventually normalize, Jagdale tells investors in a post-earnings research note. The analyst believes the chicken price-fixing allegations are unfounded. He keeps a Buy rating on Tyson's with a $75 price target. The company's "value-added earnings stream remains significantly undervalued," Jagdale writes.
WSM Williams-Sonoma
$49.47

1.35 (2.81%)

02/13/17
02/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Underperform from Neutral at Buckingham with the firm saying at current levels, shares are priced for perfection and reflect optimistic free-cash-flow estimates. The firm's analyst expects Boeing shares to underperform on downward estimate revisions, a series of negative catalysts, and multiple compression. 2. Reynolds American (RAI) downgraded to Sector Perform from Outperform at RBC Capital. 3. Occidental Petroleum (OXY) downgraded to Neutral from Buy at Mizuho with analyst Timothy Rezvan citing valuation, muted dividend growth, and increasing unit expense trends. 4. AK Steel (AKS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Evan Kurtz saying he is concerned about AK's exposure to electrical steel and heavy auto steel, which could prove to be headwinds this year. 5. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Cristina Fernandez saying the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. Fernandez said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/17
FBCO
03/13/17
NO CHANGE
Target $44
FBCO
Neutral
Williams-Sonoma price target lowered to $44 from $50 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for Williams-Sonoma to $44 from $50 ahead of Q4 results. Over the next year, the analyst believes that the combination of sluggish comps, incremental gross margin pressures from shipping and discounting, and higher investments will pressure EPS more than expected. He reiterates a Neutral rating on the shares.
03/16/17
WBLR
03/16/17
DOWNGRADE
WBLR
Market Perform
Williams-Sonoma downgraded to Market Perform from Outperform at William Blair
William Blair analyst Daniel Hofkin downgraded Williams-Sonoma to Market Perform following the company's Q4 results.
02/13/17
TLSY
02/13/17
DOWNGRADE
Target $51
TLSY
Market Perform
Williams-Sonoma downgraded to Market Perform at Telsey Advisory
As previously reported, Telsey Advisory downgraded Williams-Sonoma to Market Perform from Outperform, as analyst Cristina Fernandez said the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. The analyst, who also said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017, decreased her price target on the stock to $51 from $61.
INO Inovio
$6.87

0.26 (3.93%)

03/16/17
03/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Oracle (ORCL) was upgraded to Market Perform from Underperform at JMP Securities and to Overweight from Neutral at JPMorgan. 2. GoPro (GPRO) upgraded to Neutral from Sell at Citi with analyst Stanley Kovler saying the recent stabilization in revenue as well as the company's "significant" restructuring initiatives accelerate its path to profitability to 2017 from 2019. These developments should, at the very least, stave off the bear scenario for a few quarters, Kovler tells investors in a research note. He raised his price target for GoPro shares to $9 from $8. 2. TJX (TJX) upgraded to Conviction Buy from Buy at Goldman with analyst Matthew Fassler saying the company offers long-term secular growth along with near-term catalysts. The analyst expects TJX to grow market share at the expense of department stores. 4. Inovio (INO) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy saying it has multiple earlier stage programs moving forward with more significant data points coming in 2017 while it moves closer to its pivotal study in cervical dysplasia. He notes that his model assumes that VGX-3100 is commercialized in 2021 for cervical dysplasia. 5. Quest Diagnostics (DGX) upgraded to Neutral from Underperform at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/16/17
MAXM
03/16/17
UPGRADE
Target $10
MAXM
Buy
Inovio upgraded to Buy from Hold at Maxim
Maxim analyst Jason McCarthy upgraded Inovio to Buy from Hold and set a $10 price target on the stock, stating that it has multiple earlier stage programs moving forward with more significant data points coming in 2017 while it moves closer to its pivotal study in cervical dysplasia. He notes that his model assumes that VGX-3100 is commercialized in 2021 for cervical dysplasia.
03/16/17
PIPR
03/16/17
DOWNGRADE
Target $9
PIPR
Neutral
Inovio downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Charles Duncan downgraded Inovio to Neutral saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results.
11/07/16
AGIS
11/07/16
INITIATION
Target $12
AGIS
Buy
Inovio initiated with a Buy at Aegis
Aegis analyst Jason Wittes initiated Inovio with Buy and a $12 price target.

TODAY'S FREE FLY STORIES

NEWM

New Media

$12.75

0.045 (0.35%)

14:51
05/26/17
05/26
14:51
05/26/17
14:51
Conference/Events
New Media management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 01

    Jun

FSIC

FS Investment

$9.25

0.1 (1.09%)

14:48
05/26/17
05/26
14:48
05/26/17
14:48
Hot Stocks
Breaking Hot Stocks news story on FS Investment »

Commonwealth Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONS

Sonus

$6.91

-0.12 (-1.71%)

14:47
05/26/17
05/26
14:47
05/26/17
14:47
Conference/Events
Sonus management to meet with William Blair »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 09

    Jun

GOOG

Alphabet

$969.54

14.58 (1.53%)

, GOOGL

Alphabet Class A

$991.86

14.25 (1.46%)

14:46
05/26/17
05/26
14:46
05/26/17
14:46
Periodicals
Google creates AI-focused venture capital program, Axios reports »

Google has launched a new…

GOOG

Alphabet

$969.54

14.58 (1.53%)

GOOGL

Alphabet Class A

$991.86

14.25 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 28

    Jun

  • 19

    Jul

14:45
05/26/17
05/26
14:45
05/26/17
14:45
General news
NY Fed's 4-day reverse repo totaled $169.0 B (55 counterparties) »

NY Fed's 4-day…

OOMA

Ooma

$8.58

0.075 (0.88%)

14:29
05/26/17
05/26
14:29
05/26/17
14:29
Hot Stocks
Ooma CFO acquires 3,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 14

    Jun

SHW

Sherwin-Williams

$334.27

0.18 (0.05%)

, VAL

Valspar

$113.06

0.6 (0.53%)

14:20
05/26/17
05/26
14:20
05/26/17
14:20
Hot Stocks
Sherwin-Williams says Valspar acquisition expected to close on June 1 »

Sherwin-Williams (SHW)…

SHW

Sherwin-Williams

$334.27

0.18 (0.05%)

VAL

Valspar

$113.06

0.6 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$138.26

-0.31 (-0.22%)

, SFTBF

SoftBank

$79.50

3.295 (4.32%)

14:18
05/26/17
05/26
14:18
05/26/17
14:18
Periodicals
SoftBank considering increasing Nvidia stake over time, Bloomberg says »

Bloomberg reported…

NVDA

Nvidia

$138.26

-0.31 (-0.22%)

SFTBF

SoftBank

$79.50

3.295 (4.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jun

$NSD

NASDAQ Market Internals

14:17
05/26/17
05/26
14:17
05/26/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCRX

Ocera Therapeutics

$1.13

-0.01 (-0.88%)

14:17
05/26/17
05/26
14:17
05/26/17
14:17
Conference/Events
Ocera Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

$NYE

NYSE Market Internals

14:16
05/26/17
05/26
14:16
05/26/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$106.53

0.65 (0.61%)

14:10
05/26/17
05/26
14:10
05/26/17
14:10
Options
Repeat action in Marriott »

Repeat action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$479.98

-1.41 (-0.29%)

14:04
05/26/17
05/26
14:04
05/26/17
14:04
Hot Stocks
Chipotle says malware found during investigation of card security incident »

Chipotle Mexican Grill,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.87

0.005 (0.05%)

14:04
05/26/17
05/26
14:04
05/26/17
14:04
Conference/Events
Ford to host sales conference call »

Ford U.S. Sales Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

SPY

SPDR S&P 500 ETF Trust

$241.73

-0.03 (-0.01%)

, SPX

S&P 500

14:00
05/26/17
05/26
14:00
05/26/17
14:00
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX) is…

SPY

SPDR S&P 500 ETF Trust

$241.73

-0.03 (-0.01%)

SPX

S&P 500

AMZN

Amazon.com

$993.38

13.03 (1.33%)

GOOG

Alphabet

$969.54

14.58 (1.53%)

GOOGL

Alphabet Class A

$991.86

14.25 (1.46%)

FB

Facebook

$151.96

1.92 (1.28%)

MSFT

Microsoft

$69.62

0.85 (1.24%)

AAPL

Apple

$153.87

0.53 (0.35%)

XLI

Industrial Select Sector SPDR

$67.45

0.12 (0.18%)

XLU

Utilities SPDR

$53.38

-0.0232 (-0.04%)

XLY

Consumer Discretionary Sector SPDR

$90.63

0.16 (0.18%)

XLF

Financial Select Sector

$23.66

0.04 (0.17%)

IYR

DJ US Real Estate Index Fund

$79.09

-0.53 (-0.67%)

XLE

Energy Select Sector SPDR

$66.54

0.04 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 01

    Jun

  • 08

    Jun

  • 28

    Jun

  • 19

    Jul

TV

Grupo Televisa

$25.08

0.18 (0.72%)

14:00
05/26/17
05/26
14:00
05/26/17
14:00
Options
Short-term put sellers back in Grupo Televisa »

Short-term put sellers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:00
05/26/17
05/26
14:00
05/26/17
14:00
General news
Energy Action: Baker-Hughes »

Energy Action:…

MNK

Mallinckrodt

$43.29

2.29 (5.59%)

13:59
05/26/17
05/26
13:59
05/26/17
13:59
Hot Stocks
Mallinckrodt denied citizen petition related to Inomax »

The FDA has denied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

NSANY

Nissan

$19.34

0.06 (0.31%)

, TSLA

Tesla

$316.83

6.61 (2.13%)

13:51
05/26/17
05/26
13:51
05/26/17
13:51
Periodicals
Nissan near deal to sell battery unit for around $1B, Nikkei says »

Nissan Motor (NSANY) is…

NSANY

Nissan

$19.34

0.06 (0.31%)

TSLA

Tesla

$316.83

6.61 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 02

    Oct

PVG

Pretium Resources

$9.24

0.13 (1.43%)

13:50
05/26/17
05/26
13:50
05/26/17
13:50
Options
Call buyers active in Pretrium Resources »

Call buyers active in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
05/26/17
05/26
13:40
05/26/17
13:40
General news
Fedspeak resumes next week with SF Fed dove Williams »

Fedspeak resumes next…

IWM

iShares Trust Russell 2000 Index Fund

$137.74

0.1592 (0.12%)

, RUT

Russell 2000 Index

13:26
05/26/17
05/26
13:26
05/26/17
13:26
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$137.74

0.1592 (0.12%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
05/26/17
05/26
13:17
05/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
05/26/17
05/26
13:16
05/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$9.25

-0.31 (-3.24%)

13:15
05/26/17
05/26
13:15
05/26/17
13:15
Options
Hertz put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.